OR WAIT null SECS
- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Saneca Pharma Secures Contract Manufacturing Agreement with Xantis Pharma
PTSM: Pharmaceutical Technology Sourcing and Management
CDMO Saneca Pharma has sold registration dossiers for more than 20 pharmaceutical products to Xantis Pharma and will hold an exclusive five-year contract manufacturing agreement for the products with Xantis Pharma.
Saneca Pharma, a contract development and manufacturing organization (CDMO) based in Slovakia, announced that it has sold registration dossiers for more than 20 pharmaceutical products to Swiss company Xantis Pharma as part of an exclusive agreement. The portfolio of products will be marketed by Xantis Pharma throughout Central and Eastern Europe.
Under the terms of the agreement, the European CDMO will hold an exclusive five-year contract manufacturing agreement for the products with Xantis Pharma. Saneca Pharma will continue to act as Xantis Pharma’s agent for out-licensing opportunities for the dossiers outside of these regions.
The two firms have also committed to working together to develop nine new products in the next three years. While Saneca Pharma will use its expertise in formulation development and regulatory support, Xantis Pharma will promote the new offerings to the market.
